Imprimis Pharmaceuticals, Inc.
(NASDAQ : IMMY)

( )
IMMY PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
-10.75%19.6814.1%$423.46m
SAGESAGE Therapeutics, Inc.
-4.02%158.0310.9%$226.59m
SHPGShire PLC Sponsored ADR
-0.08%147.200.4%$159.41m
PRGOPerrigo Co. Plc
-2.27%84.076.6%$82.08m
MNKMallinckrodt Plc
-3.10%23.1218.5%$78.88m
GWPHGW Pharmaceuticals PLC Sponsored ADR
5.52%130.827.6%$60.16m
JAZZJazz Pharmaceuticals Plc
-3.65%135.502.2%$53.33m
UTHRUnited Therapeutics Corporation
-0.37%135.7814.5%$51.60m
ICPTIntercept Pharmaceuticals, Inc.
-4.03%61.6122.0%$38.01m
RVNCRevance Therapeutics, Inc.
-5.72%32.1512.2%$36.25m
MDCOMedicines Company
-1.45%27.2522.1%$35.42m
ENDPEndo International Plc
0.00%7.818.9%$32.98m
CTLTCatalent Inc
0.08%40.052.6%$31.80m
ADMSAdamas Pharmaceuticals, Inc.
-3.81%32.0816.9%$31.56m
PTLAPortola Pharmaceuticals, Inc.
-3.73%47.557.8%$30.99m

Company Profile

Imprimis Pharmaceuticals, Inc. engages in the development, production, and dispensing of innovative proprietary compounded pharmaceuticals. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in San Diego, CA.